Citius Pharmaceuticals, Inc. — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d05df0c7-bbf1-45c8-9019-ad8b871417a5/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $90.0k | 2021-10-01 – 2022-09-30 | evidence 0001213900-22-082217 |
| FY 2021 | $90.0k | 2020-10-01 – 2021-09-30 | evidence 0001213900-21-065464 |
| FY 2020 | $90.0k | 2019-10-01 – 2020-09-30 | evidence 0001213900-20-043004 |
| FY 2019 | $90.0k | 2018-10-01 – 2019-09-30 | evidence 0001213900-19-026259 |
| FY 2018 | $75.0k | 2017-10-01 – 2018-09-30 | evidence 0001213900-19-026259 |
| FY 2017 | $50.0k | 2016-10-01 – 2017-09-30 | evidence 0001213900-18-011072 |
| FY 2013 | $0 | 2010-09-09 – 2013-12-31 | evidence 0001185185-14-000368 |
| FY 2012 | $0 | 2010-09-09 – 2012-12-31 | evidence 0001185185-13-000267 |
| FY 2011 | $0 | 2010-09-09 – 2012-03-31 | evidence 0001185185-12-000973 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Citius Pharmaceuticals, Inc. — all facts · Net Income · Operating Income